Literature DB >> 7702976

An elemental correlation study in cancerous and normal breast tissue with successive clinical stages by neutron activation analysis.

A N Garg1, V Singh, R G Weginwar, V N Sagdeo.   

Abstract

Influence of trace elements in body metabolism and their physiological importance in various diseases have motivated their accurate and quantitative determination in biological tissues and fluids. Instrumental Neutron Activation Analysis (INAA) using short and long term irradiation has been employed to determine five minor elements (Cl, K, Na, Mg, P) and 15 trace elements (As, Br, Co, Cr, Cs, Cu, Fe, Hg, Mn, Rb, Sb, Se, Sc, Sr, and Zn) in cancerous and normal breast tissue from 30 patients of four clinical stages. Several elements show enhancement in cancerous breast tissue. Selenium shows maximum enhancement of 94.7% followed by K (81.6%), Sc (66.7%), Cu (58.2%) Na (48.5%), P (44.4%), and Zn (39.2%). Some elements, such as Fe, Cr, and Mn, are depressed by 30.8, 30.1, and 12.8%, respectively. These elements compete for binding sites in the cell, change its enzymatic activity and exert direct or indirect action on the carcinogenic process accelerating the growth of tumors. This is further evidenced by histopathological examination of cancerous cells showing poor cytological differentiation. An attempt has been made to correlate trace element concentrations of Se, Cu, Zn, Rb, Br, Hg, As, Co, Fe, Cr, and Mn and the ratios of Se/Zn, K/P, Cu/Zn, Na/K, and Se/Fe with the clinical stages of cancer. Inhibition of enzymatic activity caused by variation in trace element concentrations results in immunological breakdown of the body system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7702976     DOI: 10.1007/BF02789296

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  34 in total

1.  Reference values for the concentrations of As, Cd, Co, Cr, Cu, Fe, I, Hg, Mn, Mo, Ni, Pb, Se, and Zn in selected human tissues and body fluids.

Authors:  G V Iyengar
Journal:  Biol Trace Elem Res       Date:  1987-04       Impact factor: 3.738

2.  Minor and trace elemental contents of cancerous breast tissue measured by instrumental and radiochemical neutron activation analysis.

Authors:  A N Garg; R G Weginwar; V Sagdeo
Journal:  Biol Trace Elem Res       Date:  1990 Jul-Dec       Impact factor: 3.738

3.  Molecular basis of hexavalent chromium carcinogenicity: effect on gene expression.

Authors:  K E Wetterhahn; J W Hamilton
Journal:  Sci Total Environ       Date:  1989-10-01       Impact factor: 7.963

4.  [Change in zinc metabolism in malignant neoplasms].

Authors:  V M Karlinskiĭ; G G Bogomolova
Journal:  Vopr Onkol       Date:  1985

5.  Selenium levels in blood and plasma, and glutathione peroxidase activity in blood of breast cancer patients during adjuvant treatment with cyclophosphamide, methotrexate and 5-fluorouracil.

Authors:  L N Vernie; M De Vries; C Benckhuijsen; J J De Goeij; C Zegers
Journal:  Cancer Lett       Date:  1983-04       Impact factor: 8.679

6.  Treatment of early cancer of the breast (T1N0M0 and T2N0M0) on the basis of histologic characteristics.

Authors:  T F Nealon; A Nkongho; C E Grossi; R Ward; C Nealon; J F Gillooley
Journal:  Surgery       Date:  1981-03       Impact factor: 3.982

7.  Brain manganese concentrations in human aging and Alzheimer's disease.

Authors:  W R Markesbery; W D Ehmann; T I Hossain; M Alauddin
Journal:  Neurotoxicology       Date:  1984       Impact factor: 4.294

8.  Variations of zinc, calcium and magnesium in normal subjects and in patients with neoplasias.

Authors:  Z Chirulescu; C Chiriloiu; A Suciu; R Pîrvulescu
Journal:  Med Interne       Date:  1987 Oct-Dec

9.  Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease.

Authors:  G N Schrauzer; T Molenaar; S Mead; K Kuehn; H Yamamoto; E Araki
Journal:  Jpn J Cancer Res       Date:  1985-05

10.  Inhibition of human breast cancer cells by selenium.

Authors:  A M Watrach; J A Milner; M A Watrach; K A Poirier
Journal:  Cancer Lett       Date:  1984-11       Impact factor: 8.679

View more
  7 in total

1.  Assessment of individual organ doses in a realistic human phantom from neutron and gamma stimulated spectroscopy of the breast and liver.

Authors:  Matthew D Belley; William Paul Segars; Anuj J Kapadia
Journal:  Med Phys       Date:  2014-06       Impact factor: 4.071

2.  Trace elements as tumor biomarkers and prognostic factors in breast cancer: a study through energy dispersive x-ray fluorescence.

Authors:  Marina P Silva; Danilo F Soave; Alfredo Ribeiro-Silva; Martin E Poletti
Journal:  BMC Res Notes       Date:  2012-07-06

3.  Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA.

Authors:  K Charalabopoulos; A Kotsalos; A Batistatou; A Charalabopoulos; P Vezyraki; D Peschos; V Kalfakakou; A Evangelou
Journal:  Br J Cancer       Date:  2006-08-01       Impact factor: 7.640

Review 4.  Toxic elements as biomarkers for breast cancer: a meta-analysis study.

Authors:  Leila Jouybari; Marzieh Saei Ghare Naz; Akram Sanagoo; Faezeh Kiani; Fatemeh Sayehmiri; Kourosh Sayehmiri; Ali Hasanpour Dehkordi
Journal:  Cancer Manag Res       Date:  2018-01-10       Impact factor: 3.989

5.  Rubidium chloride modulated the fecal microbiota community in mice.

Authors:  Qian Chen; Zhiguo He; Yuting Zhuo; Shuzhen Li; Wenjing Yang; Liang Hu; Hui Zhong
Journal:  BMC Microbiol       Date:  2021-02-15       Impact factor: 3.605

Review 6.  A systematic review and meta-analysis on the association of serum and tumor tissue iron and risk of breast cancer.

Authors:  Akram Sanagoo; Faezeh Kiani; Marzieh Saei Gharenaz; Fatemeh Sayehmiri; Fatemeh Koohi; Leila Jouybari; Majjid Dousti
Journal:  Caspian J Intern Med       Date:  2020

Review 7.  Arsenic Exposure and Breast Cancer Risk: A Re-Evaluation of the Literature.

Authors:  Katherine Pullella; Joanne Kotsopoulos
Journal:  Nutrients       Date:  2020-10-28       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.